Published in Cell Stem Cell on March 24, 2016
Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice. Blood (2016) 0.82
Endogenous DNA Damage Leads to p53-Independent Deficits in Replicative Fitness in Fetal Murine Fancd2(-/-) Hematopoietic Stem and Progenitor Cells. Stem Cell Reports (2016) 0.75
TGF-β: a master regulator of the bone marrow failure puzzle in Fanconi anemia. Stem Cell Investig (2016) 0.75
Evolution of malignant plasmacytoma cell lines from K14E7 Fancd2-/- mouse long-term bone marrow cultures. Oncotarget (2016) 0.75
Impairment of fetal hematopoietic stem cell function in the absence of Fancd2. Exp Hematol (2016) 0.75
Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector. Stem Cell Res Ther (2016) 0.75
A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell (2009) 8.64
Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature (2007) 7.72
Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med (2006) 7.62
Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell (2007) 6.02
Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov (2012) 4.30
DNA interstrand crosslink repair and cancer. Nat Rev Cancer (2011) 4.29
Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat Cell Biol (2009) 4.15
Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell (2010) 4.11
Tracking genome engineering outcome at individual DNA breakpoints. Nat Methods (2011) 4.05
Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature (2011) 3.79
Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature (2013) 3.40
Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature (2012) 3.34
Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev (2010) 3.24
A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell (2010) 2.95
Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood (1994) 2.93
Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol Cell (2010) 2.91
Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia. Nat Genet (2011) 2.72
Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway. Science (2010) 2.67
The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nat Cell Biol (2009) 2.62
A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. Nat Cell Biol (2012) 2.51
Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. Cell Stem Cell (2014) 2.44
Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell (2012) 2.26
Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. Blood (1998) 1.93
Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature (2015) 1.82
Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov (2014) 1.80
Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1. Stem Cells (2010) 1.60
DNA damage response in adult stem cells: pathways and consequences. Nat Rev Mol Cell Biol (2011) 1.57
TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. J Clin Invest (2007) 1.53
Mouse models of Fanconi anemia. Mutat Res (2009) 1.49
NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones. Biochem Pharmacol (2011) 1.41
DNA repair is crucial for maintaining hematopoietic stem cell function. DNA Repair (Amst) (2008) 1.40
Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells. J Clin Invest (2010) 1.38
RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells. Nucleic Acids Res (2012) 1.36
Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med (2014) 1.35
Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol. Blood (2010) 1.29
Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta. Nat Med (2014) 1.21
Fanconi anemia proteins and endogenous stresses. Mutat Res (2009) 1.11
FANCD2 activates transcription of TAp63 and suppresses tumorigenesis. Mol Cell (2013) 1.11
Inhibition of homologous recombination in human cells by targeting RAD51 recombinase. J Med Chem (2012) 1.10
Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase. Cancer Res (2010) 1.10
TGFbeta1/Smad3 counteracts BRCA1-dependent repair of DNA damage. Oncogene (2005) 1.03
Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. Blood (2013) 0.99
Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair. EMBO J (2002) 0.97
The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells. Nat Genet (2012) 0.97
TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy. J Exp Med (2013) 0.96
Targeted gene therapy and cell reprogramming in Fanconi anemia. EMBO Mol Med (2014) 0.95
Direct inhibition of TNF-α promoter activity by Fanconi anemia protein FANCD2. PLoS One (2011) 0.93
BRCA2 and Smad3 synergize in regulation of gene transcription. Oncogene (2002) 0.89
TGFβ induces "BRCAness" and sensitivity to PARP inhibition in breast cancer by regulating DNA-repair genes. Mol Cancer Res (2014) 0.88
New tricks for an old fox: impact of TGFβ on the DNA damage response and genomic stability. Sci Signal (2014) 0.88